BARKER ON DRUGS(4)

April 22, 2002
Excellent Adventure: Profits and Losses in the USA Stephen Barker Director, Analyst Equity Research Department UBS Warburg (Japan) Limited The financial reporting season for Japan's pharmaceutical companies begins this month. As in previous years, the internationalizing firms with growing overseas...read more